Perfil
Laura Mondano worked as a Director of Global Regulatory Affairs at Genzyme Corp.
and as a Manager of Regulatory Affairs at both Boston Scientific Corp.
and Anika Therapeutics, Inc. She then served as the Vice President of Regulatory and Quality at Histogenics Corp.
from 2012 to 2016, and as the Vice President of Regulatory Affairs at Harvard Apparatus Regenerative Technology, Inc. Ms. Mondano received her undergraduate degree from the University of New Hampshire.
Antiguos cargos conocidos de Laura Mondano.
| Empresas | Cargo | Fin |
|---|---|---|
| OCUGEN, INC. | Consejero General | 01/02/2016 |
| ANIKA THERAPEUTICS, INC. | Consejero General | - |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Consejero General | - |
| BOSTON SCIENTIFIC CORPORATION | Consejero General | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Consejero General | - |
Formación de Laura Mondano.
| University of New Hampshire | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Health Technology |
| ANIKA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Histogenics Corp.
 Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Laura Mondano
